MS research suggests the disease may be divided into two biological subtypes that differ in how early and aggressively nerve ...

The FDA has granted breakthrough therapy designation to privosegtor for optic neuritis, a common symptom of multiple ...

Cognitive biases impact how both patients and non-patients think about MS, says columnist Ben Hofmeister, who calls education the best remedy.

Frustrated by past New Year's resolutions, columnist Desiree Lama is setting intentions to help redefine what progress with ...

The ratio between two signaling molecules may be a key marker of MS brain inflammation and help identify candidates for BTK ...

The FDA approved Scinopharm's glatiramer acetate injection, a generic version of Copaxone, to treat multiple sclerosis.

England's NICE is recommending natalizumab, sold as Tysabri and Tyruko, as an NHS-covered treatment option for people with ...

Mothers with MS face longer diagnostic delays than women without children, especially those who are employed or single.

Quantum Biopharma expects data from two now-completed, FDA-requested toxicology studies to support clinical testing of its ...

At Multiple Sclerosis News Today, stories about the keto diet, myelin repair, and vitamin D topped this year's most-read list ...

The FDA has rejected Sanofi's application seeking approval of tolebrutinib to treat certain forms of MS in its present form.

Proving her illness created an illusion of wellness for columnist Ahna Crum, but a relapse after nine years showed her she ...